Top 10 Undervalued Stocks To Invest In 2019

Talk about a Barron’s bounce!Range Resources (RRC) has soared to the top of the S&P 500 today after Barron’s touted it in the pages of the magazine this weekend.

Agence France-Presse/Getty Images

Range Resources gained 4.1% to $28.47, while the S&P 500 slipped 0.3% to2,375.31.

Barron’s Andrew Bary called Range Resources “an unappreciated energy play.” He explains why:

With major market indexes at record highs, natural-gas stocks are among the few depressed industry groups. Blame a warm winter and weakening gas prices.

Range Resources (ticker: RRC), a leading U.S. gas producer, looks undervalued. Its shares, at $27, are down 20% this year and are much below their 52-week high of $47, set last June. Range drilled the first well in the now-prolific Marcellus region of Pennsylvania more than a decade ago and amassed one of its largest land positions there610,000 acres. Its $4.2 billion purchase of Memorial Resource Development last September gave it access to what the company views as a prolific and underappreciated gas region: northern Louisiana

Top 10 Undervalued Stocks To Invest In 2019: Provident Financial Services, Inc(PFS)

Advisors’ Opinion:

  • [By Joseph Griffin]

    Clifton Bancorp (NASDAQ: CSBK) and Provident Financial Services (NYSE:PFS) are both small-cap finance companies, but which is the superior business? We will contrast the two businesses based on the strength of their valuation, profitability, institutional ownership, earnings, dividends, risk and analyst recommendations.

  • [By Shane Hupp]

    Provident Financial Services (NYSE: PFS) and Dime Community Bancshares (NASDAQ:DCOM) are both small-cap finance companies, but which is the better investment? We will compare the two companies based on the strength of their dividends, risk, institutional ownership, earnings, analyst recommendations, profitability and valuation.

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on Provident Financial Services (PFS)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Logan Wallace]

    Here are some of the media stories that may have effected Accern Sentiment Analysis’s rankings:

    Get Provident Financial Services alerts:

    Head-To-Head Review: Provident Financial (PROV) versus Provident Financial Services (PFS) (americanbankingnews.com) Head-To-Head Contrast: Territorial Bancorp (TBNK) & Provident Financial Services (PFS) (americanbankingnews.com) Q3 2018 EPS Estimates for Provident Financial Services, Inc. Decreased by Piper Jaffray (PFS) (americanbankingnews.com) Provident Financial Services, Inc. (PFS) Given Average Rating of “Hold” by Brokerages (americanbankingnews.com)

    A number of research analysts have issued reports on PFS shares. Sandler O’Neill raised shares of Provident Financial Services from a “hold” rating to a “buy” rating and set a $29.00 price objective on the stock in a research report on Friday, January 26th. ValuEngine raised shares of Provident Financial Services from a “hold” rating to a “buy” rating in a research report on Wednesday, March 7th. Zacks Investment Research downgraded shares of Provident Financial Services from a “buy” rating to a “hold” rating in a research report on Wednesday, February 21st. Boenning Scattergood reissued a “hold” rating on shares of Provident Financial Services in a research report on Monday, January 29th. Finally, Piper Jaffray reissued a “hold” rating and set a $28.00 price objective on shares of Provident Financial Services in a research report on Tuesday, January 9th. Two analysts have rated the stock with a sell rating, four have issued a hold rating and three have assigned a buy rating to the company. Provident Financial Services currently has a consensus rating of “Hold” and an average price target of $28.42.

  • [By Max Byerly]

    Provident Financial Services (NYSE: PFS) and BCB Bancorp (NASDAQ:BCBP) are both small-cap finance companies, but which is the superior stock? We will compare the two companies based on the strength of their dividends, analyst recommendations, risk, profitability, institutional ownership, valuation and earnings.

Top 10 Undervalued Stocks To Invest In 2019: Celadon Group, Inc.(CGI)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Russell Investments Group Ltd. boosted its position in shares of Celadon Group, Inc. (NYSE:CGI) by 26.7% in the 1st quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 1,347,089 shares of the transportation company’s stock after purchasing an additional 283,476 shares during the quarter. Russell Investments Group Ltd. owned about 4.76% of Celadon Group worth $4,983,000 as of its most recent filing with the Securities and Exchange Commission.

  • [By Ethan Ryder]

    Scopus Asset Management L.P. reduced its holdings in shares of Celadon Group, Inc. (NYSE:CGI) by 57.5% in the 1st quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 900,000 shares of the transportation company’s stock after selling 1,218,285 shares during the quarter. Scopus Asset Management L.P. owned approximately 3.18% of Celadon Group worth $3,330,000 as of its most recent filing with the SEC.

Top 10 Undervalued Stocks To Invest In 2019: Identiv, Inc.(INVE)

Advisors’ Opinion:

  • [By Lisa Levin] Gainers
    The Trade Desk, Inc. (NASDAQ: TTD) jumped 36.2 percent to $71.82 after the company reported upbeat results for its first quarter. The company also issued strong second-quarter and FY18 sales guidance.
    WideOpenWest, Inc. (NYSE: WOW) jumped 30.4 percent to $8.80 after the company reported Q1 results.
    MoSys, Inc. (NASDAQ: MOSY) shares surged 28.6 percent to $1.9541 after the company reported better-than-expected Q1 results and issued strong Q2 forecast.
    Boxlight Corporation (NASDAQ: BOXL) gained 24 percent to $6.39.
    Akcea Therapeutics, Inc. (NASDAQ: AKCA) shares gained 19.1 percent to $24.60. Akcea Therapeutics, an affiliate of Ionis Pharmaceuticals Inc (NASDAQ: IONS) announced that the Endocrinologic and Metabolic Drugs Advisory Committee, which met to discuss the safety and efficacy of subcutaneously injected volanesoren solution for patients with familial chylomicronemia syndrome, voted 12-8 to support its approval.
    Net 1 UEPS Technologies, Inc. (NASDAQ: UEPS) shares rose 17 percent to $10.31 after reporting Q3 results.
    ArcBest Corporation (NASDAQ: ARCB) gained 16.8 percent to $43.1457 after reporting upbeat quarterly earnings.
    Amtech Systems, Inc. (NASDAQ: ASYS) rose 16.2 percent to $8.60. Amtech posted Q2 earnings of $0.19 per share on sales of $32.783 million.
    Identiv, Inc (NASDAQ: INVE) surged 14.4 percent to $3.8450 following Q1 results.
    Omeros Corporation (NASDAQ: OMER) shares rose 14.3 percent to $18.43 following Q1 results.
    VivoPower International PLC (NASDAQ: VVPR) gained 11.5 percent to $2.71.
    Intersections Inc. (NASDAQ: INTX) gained 11.4 percent to $2.55 after reporting Q1 results.
    Noodles & Company (NASDAQ: NDLS) shares rose 10.9 percent to $8.65 following Q1 results.
    Voyager Therapeutics, Inc. (NASDAQ: VYGR) climbed 10.6 percent to $18.54 following Q1 results.
    Blink Charging Co. (NASDAQ: BLNK) rose 10.4 percent to $5.739.
    Immersion Corporation (NASDAQ: IMMR) gained 9.6 percent to $12.69

Top 10 Undervalued Stocks To Invest In 2019: ACI Worldwide, Inc.(ACIW)

Advisors’ Opinion:

  • [By Joseph Griffin]

    Q2 (NYSE: QTWO) and ACI Worldwide (NASDAQ:ACIW) are both mid-cap computer and technology companies, but which is the better stock? We will contrast the two companies based on the strength of their valuation, risk, earnings, institutional ownership, profitability, dividends and analyst recommendations.

Top 10 Undervalued Stocks To Invest In 2019: Watts Water Technologies, Inc.(WTS)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Watts Water Technologies (NYSE: WTS) and ARC Group WorldWide (NASDAQ:ARCW) are both computer and technology companies, but which is the superior investment? We will contrast the two businesses based on the strength of their risk, profitability, institutional ownership, earnings, valuation, dividends and analyst recommendations.

  • [By Stephan Byrd]

    A number of institutional investors and hedge funds have recently made changes to their positions in WTS. SeaCrest Wealth Management LLC acquired a new position in Watts Water Technologies during the fourth quarter worth about $112,000. Xact Kapitalforvaltning AB acquired a new position in shares of Watts Water Technologies in the fourth quarter valued at approximately $224,000. Sawgrass Asset Management LLC acquired a new position in shares of Watts Water Technologies in the fourth quarter valued at approximately $270,000. Koch Industries Inc. raised its position in shares of Watts Water Technologies by 22.0% in the fourth quarter. Koch Industries Inc. now owns 3,821 shares of the technology company’s stock valued at $290,000 after buying an additional 690 shares during the last quarter. Finally, Quadrature Capital Ltd acquired a new position in shares of Watts Water Technologies in the fourth quarter valued at approximately $330,000. Institutional investors own 77.22% of the company’s stock.

    ILLEGAL ACTIVITY NOTICE: “Watts Water Technologies (WTS) Expected to Post Quarterly Sales of $362.52 Million” was originally posted by Ticker Report and is owned by of Ticker Report. If you are accessing this piece of content on another publication, it was illegally stolen and republished in violation of U.S. & international copyright & trademark law. The legal version of this piece of content can be accessed at www.tickerreport.com/banking-finance/3380368/watts-water-technologies-wts-expected-to-post-quarterly-sales-of-362-52-million.html.

    Watts Water Technologies Company Profile

  • [By Ethan Ryder]

    BNP Paribas Arbitrage SA lessened its stake in Watts Water Technologies Inc (NYSE:WTS) by 40.4% in the 1st quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 14,698 shares of the technology company’s stock after selling 9,975 shares during the quarter. BNP Paribas Arbitrage SA’s holdings in Watts Water Technologies were worth $1,142,000 as of its most recent SEC filing.

  • [By Stephan Byrd]

    Northern Trust Corp lifted its stake in shares of Watts Water Technologies (NYSE:WTS) by 0.3% in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 952,176 shares of the technology company’s stock after buying an additional 3,219 shares during the period. Northern Trust Corp owned approximately 2.79% of Watts Water Technologies worth $73,984,000 at the end of the most recent quarter.

Top 10 Undervalued Stocks To Invest In 2019: Sykes Enterprises, Incorporated(SYKE)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Barrington Research reiterated their hold rating on shares of Sykes Enterprises (NASDAQ:SYKE) in a research note issued to investors on Thursday morning.

  • [By Lisa Levin]

     

    Companies Reporting After The Bell
    Hertz Global Holdings, Inc. (NYSE: HTZ) is projected to post quarterly loss at $1.31 per share on revenue of $1.97 billion.
    International Flavors & Fragrances Inc. (NYSE: IFF) is estimated to post quarterly earnings at $1.59 per share on revenue of $909.36 million.
    Zillow Group, Inc. (NASDAQ: ZG) is expected to post quarterly earnings at $0.06 per share on revenue of $294.79 million.
    General Cable Corporation (NYSE: BGC) is estimated to post quarterly earnings at $0.15 per share on revenue of $980.61 million.
    Central Garden & Pet Company (NASDAQ: CENT) is expected to post quarterly earnings at $0.84 per share on revenue of $598.45 million.
    Cabot Corporation (NYSE: CBT) is estimated to post quarterly earnings at $1 per share on revenue of $746.42 million.
    Fabrinet (NYSE: FN) is expected to post quarterly earnings at $0.71 per share on revenue of $319.71 million.
    National General Holdings Corp. (NASDAQ: NGHC) is projected to post quarterly earnings at $0.55 per share on revenue of $1.08 billion.
    The Navigators Group, Inc. (NASDAQ: NAVG) is estimated to post quarterly earnings at $0.75 per share on revenue of $320.92 million.
    Diplomat Pharmacy, Inc. (NYSE: DPLO) is expected to post quarterly earnings at $0.22 per share on revenue of $1.29 billion.
    Trex Company, Inc. (NYSE: TREX) is projected to post quarterly earnings at $1.19 per share on revenue of $172.22 million.
    AMC Entertainment Holdings, Inc. (NYSE: AMC) is expected to post quarterly earnings at $0.09 per share on revenue of $1.35 billion.
    Envision Healthcare Corporation (NYSE: EVHC) is projected to post quarterly earnings at $0.64 per share on revenue of $2.02 billion.
    Regal Beloit Corporation (NYSE: RBC) is estimated to post quarterly earnings at $1.23 per share on revenue of $869.64 million.
    Amedisys, Inc. (NASDAQ: AMED) is projected to post quarterly earnings at $0.67 per share on revenue of $39

  • [By Stephan Byrd]

    Shares of Sykes Enterprises (NASDAQ:SYKE) have been given an average recommendation of “Hold” by the seven research firms that are presently covering the stock, Marketbeat reports. Two research analysts have rated the stock with a sell rating, two have issued a hold rating and two have assigned a buy rating to the company. The average twelve-month price objective among brokerages that have updated their coverage on the stock in the last year is $31.00.

Top 10 Undervalued Stocks To Invest In 2019: Jinpan International Limited(JST)

Advisors’ Opinion:

  • [By Logan Wallace]

    A number of firms have modified their ratings and price targets on shares of JOST Werke (ETR: JST) recently:

    5/25/2018 – JOST Werke was given a new €46.00 ($53.49) price target on by analysts at Deutsche Bank AG. They now have a “buy” rating on the stock. 5/25/2018 – JOST Werke was given a new €46.00 ($53.49) price target on by analysts at Deutsche Bank AG. They now have a “buy” rating on the stock. 5/25/2018 – JOST Werke was given a new €47.00 ($54.65) price target on by analysts at Warburg Research. They now have a “buy” rating on the stock. 5/24/2018 – JOST Werke was given a new €45.00 ($52.33) price target on by analysts at JPMorgan Chase & Co.. They now have a “neutral” rating on the stock. 5/8/2018 – JOST Werke was given a new €46.00 ($53.49) price target on by analysts at Deutsche Bank AG. They now have a “buy” rating on the stock. 4/4/2018 – JOST Werke was given a new €47.00 ($54.65) price target on by analysts at Warburg Research. They now have a “buy” rating on the stock.

    Shares of JOST Werke traded down €0.15 ($0.17), hitting €38.10 ($44.30), during mid-day trading on Friday, according to MarketBeat. 8,510 shares of the company’s stock were exchanged, compared to its average volume of 35,469. JOST Werke AG has a 52 week low of €27.20 ($31.63) and a 52 week high of €47.50 ($55.23).

  • [By Joseph Griffin]

    Deutsche Bank set a €46.00 ($53.49) price target on JOST Werke (ETR:JST) in a research report sent to investors on Friday. The firm currently has a buy rating on the stock.

  • [By Joseph Griffin]

    Warburg Research set a €47.00 ($55.95) price target on JOST Werke (ETR:JST) in a report published on Friday. The firm currently has a buy rating on the stock.

Top 10 Undervalued Stocks To Invest In 2019: ADMA Biologics Inc(ADMA)

Advisors’ Opinion:

  • [By Joseph Griffin]

    Aevi Genomic Medicine (NASDAQ: GNMX) and ADMA Biologics (NASDAQ:ADMA) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their analyst recommendations, earnings, valuation, risk, institutional ownership, profitability and dividends.

  • [By Joseph Griffin]

    These are some of the media headlines that may have effected Accern Sentiment Analysis’s scoring:

    Get ADMA Biologics alerts:

    Global Drugs for Respiratory Syncytial Virus (RSV) Market 2018 Insights- Ablynx, AmVac, AlphaVax and ADMA Biologics (exclusivereportage.com) Global Drugs for Respiratory Syncytial Virus (RSV) Market 2018 View- ADMA Biologics, Ablynx, AlphaVax and AmVac (exclusivereportage.com) After-Hours Stock Movers 06/07: (ZUMZ) (DOCU) (SFIX) Higher; (MVIS) (ITI) (ADMA) Lower (more…) (streetinsider.com) Why is the 200 Simple Moving Average (SMA) so common for traders and analysts? Build-A-Bear Workshop, Inc … (thestreetpoint.com) Global Lupus Therapeutic Market 2018 by Players: ADMA Biologics, Amgen, Anthera Pharma, Bayer HealthCare (ebuzzcommunity.com)

    ADMA has been the subject of a number of analyst reports. Maxim Group set a $10.00 price objective on shares of ADMA Biologics and gave the stock a “buy” rating in a report on Monday, May 14th. ValuEngine raised shares of ADMA Biologics from a “sell” rating to a “hold” rating in a report on Monday, May 14th.

  • [By Joseph Griffin]

    Media stories about ADMA Biologics (NASDAQ:ADMA) have trended somewhat positive this week, according to Accern Sentiment. Accern identifies negative and positive media coverage by analyzing more than 20 million news and blog sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. ADMA Biologics earned a news impact score of 0.03 on Accern’s scale. Accern also assigned press coverage about the biotechnology company an impact score of 45.3142660303953 out of 100, indicating that recent media coverage is somewhat unlikely to have an effect on the company’s share price in the next several days.

Top 10 Undervalued Stocks To Invest In 2019: Alpine Total Dynamic Dividend Fund(AOD)

Advisors’ Opinion:

  • [By Logan Wallace]

    Oppenheimer & Co. Inc. lifted its stake in shares of Alpine Total Dynamic Div (NYSE:AOD) by 14.1% during the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 101,451 shares of the investment management company’s stock after acquiring an additional 12,551 shares during the period. Oppenheimer & Co. Inc. owned 0.09% of Alpine Total Dynamic Div worth $906,000 as of its most recent SEC filing.

Top 10 Undervalued Stocks To Invest In 2019: Range Resources Corporation(RRC)

Advisors’ Opinion:

  • [By Ethan Ryder]

    OppenheimerFunds Inc. lowered its holdings in Range Resources Corp. (NYSE:RRC) by 68.2% in the first quarter, HoldingsChannel.com reports. The fund owned 30,532 shares of the oil and gas exploration company’s stock after selling 65,576 shares during the quarter. OppenheimerFunds Inc.’s holdings in Range Resources were worth $444,000 at the end of the most recent reporting period.

  • [By Paul Ausick]

    Range Resources Corp. (NYSE: RRC) fell about 3.6% Monday to post a new 52-week low of $14.77 after closing at $15.30 on Friday. The 52-week high is $35.64. Volume of about 9.4 million was about 20% higher than the daily average of around 7.7 million shares traded. The company had no specific news.

  • [By Joseph Griffin]

    Range Resources Corp. (NYSE:RRC) – Equities research analysts at Seaport Global Securities raised their Q4 2018 earnings per share (EPS) estimates for shares of Range Resources in a note issued to investors on Wednesday, May 23rd. Seaport Global Securities analyst M. Kelly now anticipates that the oil and gas exploration company will post earnings per share of $0.12 for the quarter, up from their previous forecast of $0.11. Seaport Global Securities has a “Neutral” rating on the stock. Seaport Global Securities also issued estimates for Range Resources’ Q1 2019 earnings at $0.36 EPS, Q3 2019 earnings at $0.18 EPS, Q4 2019 earnings at $0.26 EPS and FY2019 earnings at $0.98 EPS.

  • [By Joseph Griffin]

    Media headlines about Range Resources (NYSE:RRC) have been trending somewhat positive on Saturday, Accern Sentiment Analysis reports. The research group identifies positive and negative press coverage by monitoring more than twenty million news and blog sources in real-time. Accern ranks coverage of public companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Range Resources earned a daily sentiment score of 0.07 on Accern’s scale. Accern also gave media headlines about the oil and gas exploration company an impact score of 46.3371462950661 out of 100, indicating that recent press coverage is somewhat unlikely to have an effect on the stock’s share price in the near future.

  • [By Shane Hupp]

    Toronto Dominion Bank increased its holdings in Range Resources Corp. (NYSE:RRC) by 25.2% in the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 123,421 shares of the oil and gas exploration company’s stock after purchasing an additional 24,839 shares during the period. Toronto Dominion Bank’s holdings in Range Resources were worth $1,794,000 as of its most recent SEC filing.

Leave a Reply

Your email address will not be published. Required fields are marked *